Blog
Roche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum
Swiss pharma giant Roche Holding AG RHHBY reported sales of CHF 30.4 billion ($38.6 billion) in the first half of 2026, down 2% year over year due to the significant appreciation of the Swiss franc.
Can Gilead's Efforts to Develop New Treatments Solidify HIV Franchise?
Gilead Sciences, Inc. GILD has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy for treatment and Descovy for prevention.
The company’s HIV business continues to maintain
WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth
West Pharmaceutical Services, Inc. WST delivered adjusted second-quarter 2026 earnings per share (EPS) of $2.37, which moved up 28.8% year over year. The figure topped the Zacks Consensus Estimate
RNR Q2 Earnings Beat on Higher Investment Income and Lower Expenses
RenaissanceRe Holdings Ltd. RNR reported second-quarter 2026 operating income of $12.92 per share, which surpassed the Zacks Consensus Estimate by 12.9%. The bottom line also improved 5.1% year
MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised
Molina Healthcare, Inc. MOH reported second-quarter 2026 adjusted earnings per share (EPS) of $1.51, which beat the Zacks Consensus Estimate by 10.2%. The bottom line declined 72.4% from the
FedEx Freight Stock Outlook After the Spin-Off and S&P 500 Debut
FedEx Freight FDXF has entered the public market as a standalone freight company. Its S&P 500 debut gives investors a clearer way to evaluate a business that was previously housed inside FedEx.The
Reasons to Retain Align Technology Stock in Your Portfolio for Now
Align Technology’s ALGN international expansion efforts to broaden the business are poised to bring significant growth in the upcoming quarters. Also, iTero is gaining from the rapidly evolving
Buy, Hold or Sell Boeing Stock? Key Insights Ahead of Q2 Earnings
The Boeing Company BA is expected to report second-quarter 2026 results on July 28, before market open. The Zacks Consensus Estimate for earnings is pegged at a loss of 34 cents per share. The Zacks
Is SITM Stock a Buy Now or Too Expensive After Its Big Run?
SiTime SITM has become a harder stock to judge after its sharp rally. The business is delivering exceptional growth, higher margins and stronger exposure to AI infrastructure.The question is whether
CoStar Group to Report Q2 Earnings: What's in Store for the Stock?
CoStar Group CSGP is slated to report second-quarter 2026 results on July 28.For second-quarter 2026, the company expects revenues to be between $922 million and $932 million, indicating 18-19%
Norfolk Southern Q2 Earnings Beat on Record Revenue and Volume Growth
Norfolk Southern Corporation (NSC) reported adjusted second-quarter 2026 earnings of $3.52 per share, up 7% year over year and 9% above the Zacks Consensus Estimate of $3.23. Railway operating
Equinix to Post Q2 Earnings: What's in Store for the Stock?
Equinix, Inc. EQIX is scheduled to report second-quarter 2026 results on July 29, after market close. The company’s quarterly results are likely to display a year-over-year rise in revenues and
GSI Technology Falls 21% in Three Months: Should You Buy the Dip?
GSI Technology, Inc. GSIT shares have lost 20.7% in the past three months against the industry’s 44.7% growth. It has also lagged the broader Zacks Computer and Technology sector’s 4.2% rise and the
FEIM Secures $18 Million in New Aerospace Contract Awards
Frequency Electronics, Inc. FEIM announced the receipt of multiple contract awards totaling approximately $18 million. The awards include an $11 million contract from a major aerospace prime
Crown Castle Q2 AFFO Beats Estimates on Lower Interest Expense
Crown Castle Inc. CCI reported second-quarter 2026 adjusted funds from operations (AFFO) per share of $1.13, up 10.8% year over year. The metric surpassed the Zacks Consensus Estimate of $1.00 by
What's in the Offing for Ventas Stock This Earnings Season?
Ventas, Inc. VTR is scheduled to report second-quarter 2026 results on July 29, after market close. The quarterly results are likely to have displayed year-over-year growth in revenues and
Huntington Q2 Earnings Match Estimates as NII & Fee Income Rise Y/Y
Huntington Bancshares Incorporated HBAN reported second-quarter 2026 adjusted earnings per share (EPS) of 39 cents, which matched the Zacks Consensus Estimate. In the prior-year quarter, the company
AAL Q2 Earnings Beat Estimates on Record Revenues, Premium Demand
American Airlines AAL reported second-quarter 2026 earnings (excluding 4 cents from non-recurring items) of 15 cents per share, down 84.2% year over year but well above the Zacks Consensus Estimate
UNP Q2 Earnings & Revenues Beat Estimates, Up Y/Y, EPS View Raised
Union Pacific Corporation UNP reported impressive second-quarter 2026 results, wherein both the earnings and revenues beat the Zacks Consensus Estimate.
Quarterly earnings (excluding 5 cents from
Reasons to Add QuidelOrtho Stock in Your Portfolio for Now
QuidelOrtho Corporation QDEL is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by mixed first-quarter 2026 results, is expected to
SiTime Stock Outlook Hinges on AI Timing Growth and Execution
SiTime SITM is becoming a more direct way for investors to track precision timing demand tied to AI infrastructure.The core question is whether SiTime can turn higher timing content in data centers
How Brand Building Is Helping Victoria's Secret Grow Faster?
Victoria’s Secret & Company VSXY reported broad-based sales strength across its key businesses, with Victoria's Secret, PINK and Beauty each delivering double-digit sales growth. The company also
CSX Q2 Earnings & Revenues Beat Estimates, Up Y/Y, EPS View Raised
CSX Corporation CSX reported impressive second-quarter 2026 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate.
Quarterly earnings per share (EPS) of 54 cents
Smith+Nephew Expands ASC Platform to Support Value-Based Care
Smith+Nephew SNN recently unveiled an expanded ASC Solutions strategy aimed at helping ambulatory surgery centers ("ASCs") improve operational efficiency, accelerate growth and deliver better


